RPRX
Royalty Pharma Plc
$27.98
Earnings Summary
Revenue | $596Mn |
Net Profits | $494.34Mn |
Net Profit Margins | 82.94% |
Highlights
Royalty Pharma Plc’s revenue jumped 5.35% since last year same period to $596Mn in the Q4 2023. On a quarterly growth basis, Royalty Pharma Plc has generated 11.13% jump in its revenue since last 3-months.
Royalty Pharma Plc’s net profit jumped 181.02% since last year same period to $494.34Mn in the Q4 2023. On a quarterly growth basis, Royalty Pharma Plc has generated 585.5% jump in its net profits since last 3-months.
Royalty Pharma Plc’s net profit margin jumped 176.9% since last year same period to 82.94% in the Q4 2023. On a quarterly growth basis, Royalty Pharma Plc has generated 516.85% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Royalty Pharma Plc post its latest quarter earnings
EPS Estimate Current Quarter | 0.99 |
EPS Estimate Current Year | 0.99 |
Highlights
Royalty Pharma Plc’s earning per share (EPS) estimates for the current quarter stand at 0.99 - a -1.98% fall from last quarter’s estimates.
Royalty Pharma Plc’s earning per share (EPS) estimates for the current year stand at 0.99.
Key Ratios
Key ratios of the Royalty Pharma Plc post its Q4 2023 earnings
Earning Per Share (EPS) | 1.15 |
Dividend Per Share (DPS) | 0.2 |
Highlights
Royalty Pharma Plc’s earning per share (EPS) fell -26.28% since last year same period to 1.15 in the Q4 2023. This indicates that the Royalty Pharma Plc has generated -26.28% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Royalty Pharma Plc declared 0.2 dividend per share during the earnings announcement for Q4 2023.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-02-15 | 1.01 | 1.15 | 13.86% |
2023-05-09 | 1.27 | 1.6 | 25.98% |
2023-08-08 | 0.81 | 0.84 | 3.7% |
2023-11-08 | 0.76 | 0.79 | 3.95% |
₹0 US Stocks a/c Opening Fee